# Inhibrx Biosciences, Inc.: Form 8-K, filed Jun 3, 2026

- Company: [Inhibrx Biosciences, Inc.](/companies/inbx.md) (CIK 2007919)
- Form: 8-K
- Filed: 2026-06-03
- Accepted by EDGAR: Jun 3, 2026, 16:02 ET
- Period: 2026-06-03
- Accession: 0002007919-26-000030
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2007919/000200791926000030/inhibrx-20260603.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2007919/000200791926000030/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2007919/000200791926000030/inhibrx-20260603.htm

Filed Jun 3, 2026.
Source: SEC EDGAR, the filing index for accession 0002007919-26-000030. Last ingested by Listed: Nov 14, 2026, 21:07 ET. No prices; not investment advice.
